New evidence of retroviral involvement in amyotrophic lateral sclerosis

Project A.L.S. funds breakthrough research

A significant proportion of patients suffering from ALS (amyotrophic lateral sclerosis), also known as Lou Gehrig’s disease or motor neuron disease, have a marker of retrovirus activity in their blood, reports the February 8 issue of the medical journal Neurology. The study was led by Dr. Jeremy A. Garson of University College London, UK and Dr. Ammar Al-Chalabi of King’s College London, UK, and was funded in full by Project A.L.S.

The research confirms and extends the results of earlier work by Drs Garson and Al-Chalabi in which they had found evidence of retroviral involvement in a group of UK patients with ALS. The present study on Americans with ALS, done in collaboration with Drs. Robert H. Brown, Jr. and Merit Cudkowicz at the Massachusetts General Hospital/Harvard Medical School, shows that 47% of ALS patients have reverse transcriptase activity detectable in their serum.

“This is a very exciting finding that points towards the possibility of retrovirus involvement in ALS. However, much work remains to be done and we are very much aware that in virology, as in other branches of medical science, finding an association is not the same as proving a cause,” said Dr. Garson.

Reverse transcriptase is an enzyme associated with retroviruses. The presence of this enzyme activity in serum therefore implies that a retrovirus may be involved in ALS. It is not yet known whether the enzyme activity detected in this study reflects activation of a so-called endogenous retrovirus, which is already present in human DNA, or infection with an external exogenous retrovirus.

Retroviruses have been known for many years to be implicated in the pathogenesis of ALS-like syndromes in certain strains of mice and in rare cases of individuals with HIV infection. Drs. Garson and Al-Chalabi have demonstrated that the previously described human retroviruses HIV and HTLV are not involved in typical ALS cases. Future work will determine whether an endogenous retrovirus is activated in ALS, or whether there is infection with a novel, exogenous ALS-associated retrovirus.

The next phase of this exciting work, funded by Project A.L.S., has recently commenced. It is hoped that further progress in this area will lead to the development of improved diagnostic tests and novel therapeutic strategies, and to a greater understanding of the fundamental causes of this progressive and ultimately fatal neurological disease.

“The important study from King’s College and University College gives new life to the hypothesis that ALS is a consequence of an atypical infection; follow-up studies will now be essential to pin down the actual offending agent,” said Dr. Brown.

Media Contact

Valerie Estess EurekAlert!

More Information:

http://www.projectals.org

All latest news from the category: Health and Medicine

This subject area encompasses research and studies in the field of human medicine.

Among the wide-ranging list of topics covered here are anesthesiology, anatomy, surgery, human genetics, hygiene and environmental medicine, internal medicine, neurology, pharmacology, physiology, urology and dental medicine.

Back to home

Comments (0)

Write a comment

Newest articles

Lighting up the future

New multidisciplinary research from the University of St Andrews could lead to more efficient televisions, computer screens and lighting. Researchers at the Organic Semiconductor Centre in the School of Physics and…

Researchers crack sugarcane’s complex genetic code

Sweet success: Scientists created a highly accurate reference genome for one of the most important modern crops and found a rare example of how genes confer disease resistance in plants….

Evolution of the most powerful ocean current on Earth

The Antarctic Circumpolar Current plays an important part in global overturning circulation, the exchange of heat and CO2 between the ocean and atmosphere, and the stability of Antarctica’s ice sheets….

Partners & Sponsors